TNXP
TNXP
NASDAQ · Biotechnology

Tonix Pharmaceuticals Holdin

$3.01
-0.23 (-7.10%)
As of Nov 15, 10:38 PM ET ·
Day Range $2.90 — $3.25
52W Range $3.21 — $20.56
Open$3.25
Previous Close$3.24
Day High$3.25
Day Low$2.90
52W High$20.56
52W Low$3.21
Volume—
Avg Volume1.21M
Market Cap62.96M
P/E Ratio—
EPS$-12.92
SectorBiotechnology

Analyst Ratings

Strong Buy
10 analysts
9 Buy 1 Hold 0 Sell
Price Target +1,253.5% upside
Current
$3.01
Target
$40.74
$28.14 $40.74 avg $50.62

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 29.92M 84.57M 86.26M
Net Income -283,142,427 -20,699,385 -25,319,011
Profit Margin -946.2% -24.5% -29.4%
EBITDA -287,362,952 -24,990,141 -25,196,528
Free Cash Flow — -20,292,095 -20,848,476
Rev Growth — +3.2% +20.0%
Debt/Equity — 0.58 0.68

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $295.03 +0.20% 50.3 520.47B
AMGN Amgen Inc $465.67 -0.30% 26.9 252.64B
GILD Gilead Sciences Inc $168.08 +0.08% — 208.95B
VRTX Vertex Pharmaceuticals Inc $538.60 -0.74% 33.9 134.82B
REGN Regeneron Pharmaceuticals $955.47 +0.45% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $165.04 +5.36% 7.7 20.98B

Quick Stats

Market Cap62.96M
P/E Ratio—
EPS$-12.92
Volume—
SectorBiotechnology